Arcadia Biosciences, Inc. (RKDA) News
Follow Arcadia Biosciences, Inc. (RKDA) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
H
Why GlucoTrack Shares Are Trading Higher By Around 118%; Here Are 20 Stocks Moving Premarket
Shares of GlucoTrack Inc (NASDAQ: GCTK ) rose sharply in pre-market trading following the announcement that its subsidiary, Lokahi Therapeutics, signed its first external, fee-for-service partnership. Innovate GBM, a non
LIVE | Sep 24, 2026, 09:05 AM UTC
M
Arcadia Biosciences shareholders approve reverse split and board election
Shareholders approved director election, stock issuance, the equity plan, a reverse split, executive pay and auditor ratification by majority vote. The meeting also authorized adjournment authority, with no shareholder q
EQUITY | Sep 10, 2026, 06:48 PM UTC
M
Arcadia Biosciences gets Nasdaq notice over $2.5M equity rule shortfall
Nasdaq notified the company it failed the $2.5 million stockholders’ equity requirement under Listing Rule 5550(b)(1), reporting $633,000 as of June 30, 2026. Trading continues on Nasdaq Capital Market.
EQUITY | Sep 04, 2026, 08:17 PM UTC
H
Arcadia Biosciences RKDA reports Q2 and first-half 2026 results
Arcadia Biosciences (RKDA) announces its second quarter and first half 2026 financial results and business highlights.
EQUITY | Aug 13, 2026, 08:06 PM UTC